Global /United States /Healthcare /Drug Manufacturers - Specialty & Generic /CURX

Curanex Pharmaceuticals Inc.

CURX

• NASDAQ: CURX • Delayed

8.60USD 5%

As of 13 June 2026, Curanex Pharmaceuticals Inc. has a market cap of $9.11M USD, ranking #41781 globally and #5385 in the United States. It ranks #3701 in the Healthcare sector, and #252 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

41781

Country Rank

5385

Sector Rank

3701

Industry Rank

252

Key Stats

Market Cap

$9.11MUSD

Enterprise Value

$235.69MUSD

Net Income (TTM)

-$435.03KUSD

PB Ratio

770.5

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Jun Liu open_in_new

Founded

2018

IPO

26 Aug 2025

Website

curanexpharma.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
5%	19%	0.3%	-16%	-34%	-2.7%	-92%	-92%	-92%

News

CURX Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	CURX Curanex Pharmaceuticals Inc ISIN: US23126K1060 Shares Out.: Shares Outstanding: 28.365M¹ Shares Float: 8.72M² TV: TradingView: NASDAQ: CURX SA: Stock Analysis: NASDAQ: CURX YF: Yahoo Finance: CURX GF: Google Finance: NASDAQ: CURX NQ: NASDAQ: CURX BA: Barron's: CURX MS: Morningstar: XNAS: CURX	8.60 USD	TV: TradingView: NASDAQ: CURX SA: Stock Analysis: NASDAQ: CURX YF: Yahoo Finance: CURX GF: Google Finance: NASDAQ: CURX NQ: NASDAQ: CURX BA: Barron's: CURX MS: Morningstar: XNAS: CURX

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Curanex Pharmaceuticals Inc.

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. The company was founded in 1996 and is headquartered in Jericho, New York.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (United States)

Name	Market Cap (USD) diff.	PE	Country
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 325K%	-	United States
Indivior PLC LSE: INDV	$2.07B 1.54B GBP 23K%	-	United States
Endo, Inc. OTCMKTS: NDOI	$1.8B 20K%	0.4	United States
Dynavax Technologies Corp. NASDAQ: DVAX	$1.76B 19K%	-	United States
ArriVent BioPharma, Inc. NASDAQ: AVBP	$1.33B 14K%	-	United States
BellRing Brands, Inc. NYSE: BRBR	$1.02B 11K%	12.1	United States

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$36.75B 108.92B ILS 404K%	24.2	Israel
Zhejiang NHU Company Ltd. SHE: 002001	$15.84B 107.34B CNY 174K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.16B 1.06T INR 122K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.04B 1.05T INR 121K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.09B 61.6B CNY 100K%	80.6	China
ABIVAX Société Anonyme EPA: ABVX	$8.74B 7.57B EUR 96K%	-	France

chevron_leftBack